Physiological and pharmacodynamic considerations for route of EPO administration

被引：0
|
作者：
Besarab, A [1 ]
机构：
[1] Robert C Byrd Hlth Sci Ctr, Div Nephrol, Dept Med, Morgantown, WV 26506 USA
来源：
SEMINARS IN NEPHROLOGY | 2000年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364 / 374
页数：11
相关论文
共 50 条
  • [1] GLUCOCORTICOIDS FOR THE INTRAARTICULAR ADMINISTRATION PHARMACODYNAMIC CONSIDERATIONS
    HOCHHAUS, G
    MOLLMANN, H
    BARTH, J
    AKTUELLE RHEUMATOLOGIE, 1990, 15 (02) : 66 - 69
  • [2] Chronic Administration of Melatonin: Physiological and Clinical Considerations
    Givler, Donald
    Givler, Amy
    Luther, Patrick M.
    Wenger, Danielle M.
    Ahmadzadeh, Shahab
    Shekoohi, Sahar
    Edinoff, Amber N.
    Dorius, Bradley K.
    Baptiste, Carlo Jean
    Cornett, Elyse M.
    Kaye, Adam M.
    Kaye, Alan D.
    NEUROLOGY INTERNATIONAL, 2023, 15 (01): : 518 - 533
  • [3] INFLUENCE OF ROUTE OF ADMINISTRATION ON PHYSIOLOGICAL AVAILABILITY OF LEVODOPA IN DOGS
    COTLER, S
    HOLAZO, A
    BOXENBAUM, HG
    KAPLAN, SA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (06) : 822 - 827
  • [4] The route of nutritional support in the critically ill: Physiological and economical considerations
    Frost, P
    Bihari, D
    NUTRITION, 1997, 13 (09) : S58 - S63
  • [5] Effect of Route of EPO Administration on Hemodialysis Arteriovenous Vascular Access Failure: A Randomized Controlled Trial
    Lee, Young-Ki
    Koo, Ja-Ryong
    Kim, Jin-Kyung
    Park, In-Il
    Joo, Min-Ha
    Yoon, Jong-Woo
    Noh, Jung-Woo
    Vaziri, Nosratola D.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (05) : 815 - 822
  • [6] THE DISSOCIATION OF GM-CSF EFFICACY FROM TOXICITY ACCORDING TO ROUTE OF ADMINISTRATION - A PHARMACODYNAMIC STUDY
    CEBON, J
    LIESCHKE, GJ
    BURY, RW
    MORSTYN, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) : 144 - 150
  • [7] Pharmacokinetic and pharmacodynamic studies of iloperidone-loaded lipid nanoemulsions via oral route of administration
    Narala, Arjun
    Suram, Dinesh
    Veerabrahma, Kishan
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47 (04) : 618 - 625
  • [8] PHARMACODYNAMIC CONSIDERATIONS IN THE USE OF DIURETICS
    BRATER, DC
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 : 45 - 62
  • [9] Development of BiosimilarsPharmacokinetic and Pharmacodynamic Considerations
    Wang, Yow-Ming C.
    Chow, Andrew T.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (01) : 46 - 61
  • [10] COST CONSIDERATIONS OF ANALGESIC THERAPY - AN ANALYSIS OF THE EFFECTS OF DOSING FREQUENCY AND ROUTE OF ADMINISTRATION
    GOUGHNOUR, BR
    POSTGRADUATE MEDICAL JOURNAL, 1991, 67 : S87 - S91
12345